329 related articles for article (PubMed ID: 22768844)
1. A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets.
Taneera J; Lang S; Sharma A; Fadista J; Zhou Y; Ahlqvist E; Jonsson A; Lyssenko V; Vikman P; Hansson O; Parikh H; Korsgren O; Soni A; Krus U; Zhang E; Jing XJ; Esguerra JL; Wollheim CB; Salehi A; Rosengren A; Renström E; Groop L
Cell Metab; 2012 Jul; 16(1):122-34. PubMed ID: 22768844
[TBL] [Abstract][Full Text] [Related]
2. Whole-Genome Bisulfite Sequencing of Human Pancreatic Islets Reveals Novel Differentially Methylated Regions in Type 2 Diabetes Pathogenesis.
Volkov P; Bacos K; Ofori JK; Esguerra JL; Eliasson L; Rönn T; Ling C
Diabetes; 2017 Apr; 66(4):1074-1085. PubMed ID: 28052964
[TBL] [Abstract][Full Text] [Related]
3. Reduced insulin secretion correlates with decreased expression of exocytotic genes in pancreatic islets from patients with type 2 diabetes.
Andersson SA; Olsson AH; Esguerra JL; Heimann E; Ladenvall C; Edlund A; Salehi A; Taneera J; Degerman E; Groop L; Ling C; Eliasson L
Mol Cell Endocrinol; 2012 Nov; 364(1-2):36-45. PubMed ID: 22939844
[TBL] [Abstract][Full Text] [Related]
4. MC1568 improves insulin secretion in islets from type 2 diabetes patients and rescues β-cell dysfunction caused by Hdac7 upregulation.
Daneshpajooh M; Eliasson L; Bacos K; Ling C
Acta Diabetol; 2018 Dec; 55(12):1231-1235. PubMed ID: 30088095
[TBL] [Abstract][Full Text] [Related]
5. Expression profiling of cell cycle genes in human pancreatic islets with and without type 2 diabetes.
Taneera J; Fadista J; Ahlqvist E; Zhang M; Wierup N; Renström E; Groop L
Mol Cell Endocrinol; 2013 Aug; 375(1-2):35-42. PubMed ID: 23707792
[TBL] [Abstract][Full Text] [Related]
6. Trans-11 vaccenic acid improves insulin secretion in models of type 2 diabetes in vivo and in vitro.
Wang X; Gupta J; Kerslake M; Rayat G; Proctor SD; Chan CB
Mol Nutr Food Res; 2016 Apr; 60(4):846-57. PubMed ID: 27061233
[TBL] [Abstract][Full Text] [Related]
7. An Islet-Targeted Genome-Wide Association Scan Identifies Novel Genes Implicated in Cytokine-Mediated Islet Stress in Type 2 Diabetes.
Sharma PR; Mackey AJ; Dejene EA; Ramadan JW; Langefeld CD; Palmer ND; Taylor KD; Wagenknecht LE; Watanabe RM; Rich SS; Nunemaker CS
Endocrinology; 2015 Sep; 156(9):3147-56. PubMed ID: 26018251
[TBL] [Abstract][Full Text] [Related]
8. Systems biology approach reveals genome to phenome correlation in type 2 diabetes.
Jain P; Vig S; Datta M; Jindel D; Mathur AK; Mathur SK; Sharma A
PLoS One; 2013; 8(1):e53522. PubMed ID: 23308243
[TBL] [Abstract][Full Text] [Related]
9. Altered serotonin (5-HT) 1D and 2A receptor expression may contribute to defective insulin and glucagon secretion in human type 2 diabetes.
Bennet H; Balhuizen A; Medina A; Dekker Nitert M; Ottosson Laakso E; Essén S; Spégel P; Storm P; Krus U; Wierup N; Fex M
Peptides; 2015 Sep; 71():113-20. PubMed ID: 26206285
[TBL] [Abstract][Full Text] [Related]
10.
Kong Y; Sharma RB; Ly S; Stamateris RE; Jesdale WM; Alonso LC
Diabetes; 2018 May; 67(5):872-884. PubMed ID: 29432124
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel genes for glucose metabolism based upon expression pattern in human islets and effect on insulin secretion and glycemia.
Taneera J; Fadista J; Ahlqvist E; Atac D; Ottosson-Laakso E; Wollheim CB; Groop L
Hum Mol Genet; 2015 Apr; 24(7):1945-55. PubMed ID: 25489054
[TBL] [Abstract][Full Text] [Related]
12. Genetic regulatory signatures underlying islet gene expression and type 2 diabetes.
Varshney A; Scott LJ; Welch RP; Erdos MR; Chines PS; Narisu N; Albanus RD; Orchard P; Wolford BN; Kursawe R; Vadlamudi S; Cannon ME; Didion JP; Hensley J; Kirilusha A; ; Bonnycastle LL; Taylor DL; Watanabe R; Mohlke KL; Boehnke M; Collins FS; Parker SC; Stitzel ML
Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2301-2306. PubMed ID: 28193859
[TBL] [Abstract][Full Text] [Related]
13. Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes.
Miguel-Escalada I; Bonàs-Guarch S; Cebola I; Ponsa-Cobas J; Mendieta-Esteban J; Atla G; Javierre BM; Rolando DMY; Farabella I; Morgan CC; García-Hurtado J; Beucher A; Morán I; Pasquali L; Ramos-Rodríguez M; Appel EVR; Linneberg A; Gjesing AP; Witte DR; Pedersen O; Grarup N; Ravassard P; Torrents D; Mercader JM; Piemonti L; Berney T; de Koning EJP; Kerr-Conte J; Pattou F; Fedko IO; Groop L; Prokopenko I; Hansen T; Marti-Renom MA; Fraser P; Ferrer J
Nat Genet; 2019 Jul; 51(7):1137-1148. PubMed ID: 31253982
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide meta-analysis of genetic susceptible genes for Type 2 Diabetes.
Hale PJ; López-Yunez AM; Chen JY
BMC Syst Biol; 2012; 6 Suppl 3(Suppl 3):S16. PubMed ID: 23281828
[TBL] [Abstract][Full Text] [Related]
15. The Transcription Factor Nfatc2 Regulates β-Cell Proliferation and Genes Associated with Type 2 Diabetes in Mouse and Human Islets.
Keller MP; Paul PK; Rabaglia ME; Stapleton DS; Schueler KL; Broman AT; Ye SI; Leng N; Brandon CJ; Neto EC; Plaisier CL; Simonett SP; Kebede MA; Sheynkman GM; Klein MA; Baliga NS; Smith LM; Broman KW; Yandell BS; Kendziorski C; Attie AD
PLoS Genet; 2016 Dec; 12(12):e1006466. PubMed ID: 27935966
[TBL] [Abstract][Full Text] [Related]
16. Insulinotropic and antidiabetic effects of 17β-estradiol and the GPR30 agonist G-1 on human pancreatic islets.
Kumar R; Balhuizen A; Amisten S; Lundquist I; Salehi A
Endocrinology; 2011 Jul; 152(7):2568-79. PubMed ID: 21521748
[TBL] [Abstract][Full Text] [Related]
17. Microarray analysis of isolated human islet transcriptome in type 2 diabetes and the role of the ubiquitin-proteasome system in pancreatic beta cell dysfunction.
Bugliani M; Liechti R; Cheon H; Suleiman M; Marselli L; Kirkpatrick C; Filipponi F; Boggi U; Xenarios I; Syed F; Ladriere L; Wollheim C; Lee MS; Marchetti P
Mol Cell Endocrinol; 2013 Mar; 367(1-2):1-10. PubMed ID: 23246353
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic islet chromatin accessibility and conformation reveals distal enhancer networks of type 2 diabetes risk.
Greenwald WW; Chiou J; Yan J; Qiu Y; Dai N; Wang A; Nariai N; Aylward A; Han JY; Kadakia N; Regue L; Okino ML; Drees F; Kramer D; Vinckier N; Minichiello L; Gorkin D; Avruch J; Frazer KA; Sander M; Ren B; Gaulton KJ
Nat Commun; 2019 May; 10(1):2078. PubMed ID: 31064983
[TBL] [Abstract][Full Text] [Related]
19. Genetic risk converges on regulatory networks mediating early type 2 diabetes.
Walker JT; Saunders DC; Rai V; Chen HH; Orchard P; Dai C; Pettway YD; Hopkirk AL; Reihsmann CV; Tao Y; Fan S; Shrestha S; Varshney A; Petty LE; Wright JJ; Ventresca C; Agarwala S; Aramandla R; Poffenberger G; Jenkins R; Mei S; Hart NJ; Phillips S; Kang H; Greiner DL; Shultz LD; Bottino R; Liu J; Below JE; ; Parker SCJ; Powers AC; Brissova M
Nature; 2023 Dec; 624(7992):621-629. PubMed ID: 38049589
[TBL] [Abstract][Full Text] [Related]
20. Anti-diabetic action of all-trans retinoic acid and the orphan G protein coupled receptor GPRC5C in pancreatic β-cells.
Amisten S; Mohammad Al-Amily I; Soni A; Hawkes R; Atanes P; Persaud SJ; Rorsman P; Salehi A
Endocr J; 2017 Mar; 64(3):325-338. PubMed ID: 28228611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
